Hamed Shahbazi Buys Shares of NAGE
Hamed Shahbazi acquired 31,746 shares of NAGE on June 24, 2026.
Key Points
- Hamed Shahbazi purchased 31,746 shares of NAGE on June 24, 2026, with shares trading near $3.42.
- Shares of NAGE have a 52-week range with a low of $3.42, while institutional investors have been active in adjusting their positions.
- Analysts from HC Wainwright & Co. and Canaccord Genuity maintained buy ratings on NAGE, with price targets up to $23.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Hamed Shahbazi, an insider at NAGE, bought 31,746 shares of the company on June 24, 2026. This transaction was not part of a pre-planned trading program. Shares of NAGE were trading near $3.42 on Saturday.
Other Institutional Activity in NAGE
BlackRock, Inc. reduced its holdings in NAGE by 204,090 shares, bringing its total to 3,871,619 shares valued at about $17,073,839. SteelPeak Wealth, LLC opened a new position with 3,373,000 shares worth approximately $14,874,930. Arrowstreet Capital, Limited Partnership increased its stake by 761,685 shares, ending with 2,378,437 shares valued at around $10,488,907. Vanguard Capital Management LLC also initiated a new position with 2,149,277 shares worth about $9,478,312. Tieton Capital Management, LLC grew its holdings by 384,062 shares, totaling 2,029,155 shares valued at approximately $8,949,000.
Insider Buying and Selling at Niagen Bioscience, Inc.
On June 24, 2026, several insiders, including Frank Jaksch Jr., Gary Ng Wang Yu, Ann Cohen, Kristin Patrick, Steven Rubin, and Hamed Shahbazi, each purchased 31,746 shares of NAGE. These transactions were not executed under Rule 10b5-1 plans.
Analysts Set New Price Targets
On May 11, 2026, HC Wainwright & Co. maintained a buy rating on NAGE with a price target of $11. Canaccord Genuity also maintained its buy rating with a target of $10 on May 5, 2026. The consensus among analysts remains a buy, with a mean price target reflecting ongoing positive sentiment.
About NAGE
NAGE operates in the technology sector, focusing on innovative solutions within its industry. The company is known for its cutting-edge developments and is committed to advancing technology in its field. NAGE continues to expand its market presence and enhance its product offerings to meet the growing demands of its customers.
Bottom Line
Hamed Shahbazi's recent purchase of NAGE shares reflects insider confidence, though it's important to note that insider transactions can occur for various reasons. Institutional investors have also been adjusting their positions in NAGE, indicating ongoing interest in the company. Analyst ratings remain positive, with several firms maintaining buy ratings and setting substantial price targets.
Get Niagen Bioscience, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NAGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.